Galecto - Wutah pendapatan triwulanan GLTO

Galecto, Inc. (GLTO) - logo korporat

Galecto, Inc. (GLTO) develops patent-protected inhibitors to combat cancer and fibrosis. The company is currently reallocating resources, shifting its focus toward metabolic pathologies following a series of setbacks. Quarterly commercial revenue growth reflects income dynamics where the current status is 0.00. Unique developments enable the monetization of treatments for chronic diseases that require long-term medication.

GLTO Tingkat wutah dodolan sajrone kuartal Galecto Corp (04.07.2022 - 10.03.2026)

Rincian analitis perusahaan Galecto, Inc.

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis kabeh metrik perusahaan:GLTO - Galecto, Inc.
Produk sing diprodhuksi galecto.com

The resilience of Galecto, Inc. (GLTO) is based on synergy with clinical institutes in the development of galectin inhibitors, which is directly reflected in revenue dynamics. The quarterly revenue growth trajectory measures the percentage change in sales volume of the current period compared to the same quarter of the previous year, allowing investors to assess the pace of business scaling and determine the fair value of the asset relative to industry benchmarks.

Analisis pesaing Galecto, Inc.

ASND - Wutah pendapatan kuartal marang kuartal|MDGL: Wutah pendapatan kuartal marang kuartal|CORT: Wutah pendapatan triwulanan|RYTM - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Akero Corp|Metsera Therapeutics (MTSR) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal moonlaketx.com (MLTX)|Wutah dodolan triwulanan Crinetics Pharmaceuticals CRNX|Wutah pendapatan kuartal marang kuartal NewAmsterdam Pharma N.V. NAMS|Tingkat wutah dodolan sajrone kuartal Soleno Therapeutics Inc (SLNO)|FOLD - Wutah pendapatan kuartal marang kuartal|ETNB: Wutah pendapatan kuartal marang kuartal|AGIO: Wutah pendapatan triwulanan|Structure Therapeutics Inc. - Tambahing pendapatan triwulanan|MDXG (MiMedx Corp) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Rezolute Inc RZLT|Wutah pendapatan triwulanan LXRX|Tingkat wutah dodolan sajrone kuartal MBX Corp|Altimmune Pharma - Wutah dodolan triwulanan|Wutah pendapatan triwulanan aardvarktherapeutics.com AARD|SGMT: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan BIOA (BioAge Labs)|BMEA: Wutah pendapatan triwulanan|QNCX: Owah-owahan dodolan kuartal marang kuartal|GUTS (Fractyl Health, Inc.) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan vtvtherapeutics.com|Wutah dodolan triwulanan ATPC (Agape ATP Corp)|Tingkat wutah dodolan sajrone kuartal Pluristem Therapeutics|Wutah pendapatan kuartal marang kuartal synlogictx.com SYBX|LPCN: Wutah dodolan kuartal marang kuartal|MTNB - Wutah pendapatan kuartal marang kuartal|Spruce Biosciences, Inc. (SPRB) - Wutah dodolan triwulanan|Carmell Therapeutics (CTCX) - Wutah pendapatan kuartal marang kuartal|Lumos Pharma - Tambahing pendapatan triwulanan|ONVO (Organovo Corp) - Wutah pendapatan triwulanan|Radius Pharmaceuticals (RDUS) - Tingkat wutah dodolan sajrone kuartal